Oncologie

OverviewSuggest Edit

Oncologie is an oncology biotech company dedicated to biomarker-driven development of large and small molecules. The Company is developing multiple global programs whose mechanisms are designed to combine with immune checkpoint inhibitors to improve survival benefits.

TypePrivate
Founded2018
HQBoston, MA, US
Websiteoncologie.com

Latest Updates

Employees (est.) (May 2021)29(+8%)
Cybersecurity ratingAMore

Key People/Management at Oncologie

Laura Benjamin

Laura Benjamin

President, Founder, CEO
David Malek

David Malek

CBO
Hagop Youssoufian

Hagop Youssoufian

Chief Medical Officer
Show more

Oncologie Office Locations

Oncologie has offices in Boston and Shanghai
Boston, MA, US (HQ)
Boston, MA, USA
Show all (2)

Oncologie Financials and Metrics

Summary Metrics

Founding Date

2018

Oncologie total Funding

$96.5 m

Oncologie latest funding size

$80 m

Time since last funding

2 years ago

Oncologie investors

Oncologie's latest funding round in June 2019 was reported to be $80 m. In total, Oncologie has raised $96.5 m
Show all financial metrics

Oncologie Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Oncologie Online and Social Media Presence

Embed Graph

Oncologie News and Updates

Oncologie Closes an $80M Series B Financing for Clinical-Stage Pipeline

BOSTON, June 10, 2019 /PRNewswire/ -- Oncologie, an innovative biopharmaceutical company using proprietary biomarkers to drive clinical development of next-generation oncology therapeutics, announced today that it has closed an $80M Series B financing. Existing investors, led by Nan Fung...

Oncologie Blogs

Oncologie Announces Key Updates and Planned Activities for its Clinical Programs and RNA-based Biomarker Platform

  Press Release | June 16, 2020 | Source: Oncologie Phase 2 Trial with Bavituximab in Patients with Gastric Cancer on Track to Report Preliminary Results During the Second Half of 2020 Phase 1b Trial with Navicixizumab in Patients with Ovarian Cancer Recently Presented at the...

Oncologie, Inc. Announces Collaboration with Moffitt Cancer Center to Advance the Development of Precision Medicine for the Treatment of Gastric and Gastrointestinal Cancers

  Press Release | February 25, 2020 | Source: Oncologie Waltham, MA. February 25, 2020 — Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment (TME), announced today that it has entered into a collaboration agreemen…

Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab

Press Release | January 13, 2020 | Source: Oncologie Oncologie receives exclusive global license to develop and commercialize navicixizumab London, Redwood City, Calif., and Boston, January 13, 2020 – Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or the “Company,” and Oncologie, Inc. (…

Oncologie Announces First Patient Enrolled in Global Phase 2 Study of Bavituximab Plus KEYTRUDA® (Pembrolizumab) for Advanced Gastric or Gastroesophageal Cancer

Press Release | October 09, 2019 | Source: Oncologie – The initiated study will further evaluate the antitumor activity, safety and tolerability of bavituximab plus KEYTRUDA® in a gastric cancer population – Oncologie’s first global study for bavituximab plans enrollment in the US, UK, Taiwan and...

Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Gastric or Gastroesophageal Cancer

Press Release | August 12, 2019 | Source: Oncologie WALTHAM, Mass., Aug. 12, 2019 — Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment, today announced that it has entered into a clinical collaboration agreement …

Oncologie Frequently Asked Questions

  • When was Oncologie founded?

    Oncologie was founded in 2018.

  • Who are Oncologie key executives?

    Oncologie's key executives are Laura Benjamin, David Malek and Hagop Youssoufian.

  • How many employees does Oncologie have?

    Oncologie has 29 employees.

  • Who are Oncologie competitors?

    Competitors of Oncologie include TargaGenix, Avalia Immunotherapies and Rakuten Medical.

  • Where is Oncologie headquarters?

    Oncologie headquarters is located at Boston, MA, USA, Boston.

  • Where are Oncologie offices?

    Oncologie has offices in Boston and Shanghai.

  • How many offices does Oncologie have?

    Oncologie has 2 offices.